chrX-150658044-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000252.3(MTM1):c.1260+17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00896 in 1,115,153 control chromosomes in the GnomAD database, including 44 homozygotes. There are 3,073 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0066 ( 5 hom., 237 hem., cov: 23)
Exomes 𝑓: 0.0092 ( 39 hom. 2836 hem. )
Consequence
MTM1
NM_000252.3 intron
NM_000252.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.607
Genes affected
MTM1 (HGNC:7448): (myotubularin 1) This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-150658044-A-G is Benign according to our data. Variant chrX-150658044-A-G is described in ClinVar as [Benign]. Clinvar id is 255621.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-150658044-A-G is described in Lovd as [Likely_benign]. Variant chrX-150658044-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00661 (744/112605) while in subpopulation NFE AF= 0.00885 (472/53326). AF 95% confidence interval is 0.00819. There are 5 homozygotes in gnomad4. There are 237 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTM1 | NM_000252.3 | c.1260+17A>G | intron_variant | ENST00000370396.7 | NP_000243.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTM1 | ENST00000370396.7 | c.1260+17A>G | intron_variant | 1 | NM_000252.3 | ENSP00000359423 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00661 AC: 744AN: 112551Hom.: 5 Cov.: 23 AF XY: 0.00683 AC XY: 237AN XY: 34683
GnomAD3 genomes
AF:
AC:
744
AN:
112551
Hom.:
Cov.:
23
AF XY:
AC XY:
237
AN XY:
34683
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00670 AC: 1169AN: 174442Hom.: 6 AF XY: 0.00651 AC XY: 399AN XY: 61330
GnomAD3 exomes
AF:
AC:
1169
AN:
174442
Hom.:
AF XY:
AC XY:
399
AN XY:
61330
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00922 AC: 9246AN: 1002548Hom.: 39 Cov.: 22 AF XY: 0.00996 AC XY: 2836AN XY: 284744
GnomAD4 exome
AF:
AC:
9246
AN:
1002548
Hom.:
Cov.:
22
AF XY:
AC XY:
2836
AN XY:
284744
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00661 AC: 744AN: 112605Hom.: 5 Cov.: 23 AF XY: 0.00682 AC XY: 237AN XY: 34747
GnomAD4 genome
AF:
AC:
744
AN:
112605
Hom.:
Cov.:
23
AF XY:
AC XY:
237
AN XY:
34747
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 07, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 12, 2016 | - - |
Severe X-linked myotubular myopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at